Showing results (11-20 of 17) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Rheumatology (Oxford, England)|February 10, 2015
Young people's decisions about biologic therapies: who influences them and how?Ruth I Hart, Helen E Foster, Janet E McDonagh, et al.International Journal of Orthopedics|April 30, 2020
Clinical Outcomes and Shoulder Kinematics for the "Gray Zone" Extra-articular Scapula Fracture in 5 PatientsJyoti Sharma, Candice Maenza, Andrea Myers, et al.Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society|August 28, 2014
Dosage uniformity problems which occur due to technological errors in extemporaneously prepared suppositories in hospitals and pharmaciesEva Kalmár, Jason Richard Lasher, Thomas Dean Tarry, et al.Cancer Science|February 7, 2019
Phase I dose-escalation study of capmatinib (INC280) in Japanese patients with advanced solid tumorsTaito Esaki, Fumihiko Hirai, Akitaka Makiyama, et al.Investigational New Drugs|May 16, 2020
A phase 1b study of the MET inhibitor capmatinib combined with cetuximab in patients with MET-positive colorectal cancer who had progressed following anti-EGFR monoclonal antibody treatmentJean-Pierre Delord, Guillem Argilés, Jerôme Fayette, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2023
Canakinumab as Adjuvant Therapy in Patients With Completely Resected Non-Small-Cell Lung Cancer: Results From the CANOPY-A Double-Blind, Randomized Clinical TrialEdward B Garon, Shun Lu, Yasushi Goto, et al.Journal of Experimental & Clinical Cancer Research : CR|June 2, 2022
A first-in-human phase 1/2 study of FGF401 and combination of FGF401 with spartalizumab in patients with hepatocellular carcinoma or biomarker-selected solid tumorsStephen L Chan, Martin Schuler, Yoon-Koo Kang, et al.Pageof 2